Ivermectin Reproposing for Mild Stage COVID-19 Outpatients (IVER-Leve)

Clinical Trial ID NCT04784481

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04784481

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 2004 7.57
2 The pharmacokinetics and interactions of ivermectin in humans--a mini-review. AAPS J 2008 1.06
3 In silico drug repositioning: what we need to know. Drug Discov Today 2012 0.93
4 Sample size calculations in clinical research. Anesthesiology 2002 0.78
Next 100